AMED Amedisys Inc

$228.74
$4.15 (1.85%)

AMED Stock Analysis Overview

What this means: Amedisys Inc (AMED) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 76 means that our comprehensive methodology rates Amedisys Inc above 76% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Amedisys Inc (AMED) Analyst Forecast

Next 12 months ➝MEAN$253.85+10.98%HIGH$290.00+26.78%LOW$190.00-16.94%Current Price$228.7452-week High$248.9652-week Low$121.00
  • Last Price$228.74
  • Previous Close$224.59
  • Change $4.15
  • Open$224.97
  • Volume52,482
  • Avg. Volume (100-day)310,537
  • Market Capitalization$7B
  • Days Range $216.20 - $228.81
  • 52-week Range $121.00 - $248.96
  • Dividend Yield
  • Ex. Dividend Date
  • P-E58.2
  • EPS3.86
  • Earnings Date11/03/2020
  • SectorHealthcare
  • IndustryMedical Care Facilities
  • Avg. Analyst Rec.
  • Beta0.883
  • PEG Ratio3.31
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.